← All trials
NCT02096302
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2011
- Primary completion
- Nov 1, 2012
- Completion date
- Jun 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 194
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Laboratorios OrdesaLead sponsor
- Harrison Clinical ResearchCollaborator
- Hospital Joan XXIII de Tarragona, Tarragona, SpainOverall official - principal investigator
- Rovira i Virgili UniversityOverall official - principal investigator
- Universidad Autonoma de MadridStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.